UIUC Office of Technology Management
Published on UIUC Office of Technology Management (https://origin.otm.illinois.edu)

Home > Rapamycin-resistant mTOR C2C12 cell line

Rapamycin-resistant mTOR C2C12 cell line

Rapamycin-resistant mTOR C2C12 cell line [1]

Professor Jie Chen has developed a mouse myoblast cell line whose mTOR pathway is insensitive to the presence of rapamycin. This invention is useful for studying related biochemical pathways and the drivers for skeletal myogenesis.

Publications:

The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. Erbay, Chen. J. Biol. Chem. 2001.

IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. Erbay, Park, Nuzzi, Schoenherr, Chen. J. Cell Biol. 2003.

Jie
Chen

Inventors:

The Office of Technology Management
319 Ceramics Building
105 South Goodwin Avenue
Urbana, IL 61801
Phone: 217.333.7862
Fax: 217.265.5530
Email: otm@illinois.edu

Source URL:https://origin.otm.illinois.edu/technologies/rapamycin-resistant-mtor-c2c12-cell-line

Links
[1] https://origin.otm.illinois.edu/technologies/rapamycin-resistant-mtor-c2c12-cell-line